Processa Pharmaceuticals, Inc. (PCSA) Social Stream
PROCESSA PHARMACEUTICALS INC (PCSA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PCSA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 2 | $22 | $15 | $18.5 | $0.288 | 6323.61% |
| 2022-01-27 | 1 | $17 | $17 | $17 | $0.288 | 5802.78% |
| 2022-04-22 | 2 | $17 | $9 | $13 | $0.288 | 4413.89% |
| 2022-05-13 | 2 | $17 | $9 | $11.666 | $0.288 | 3950.69% |
| 2022-05-27 | 3 | $17 | $9 | $11.666 | $0.288 | 3950.69% |
| 2022-08-15 | 3 | $11 | $9 | $9.666 | $0.288 | 3256.25% |
| 2022-09-15 | 3 | $9 | $8 | $8.666 | $0.288 | 2909.03% |
| 2022-11-10 | 3 | $9 | $5 | $7.666 | $0.288 | 2561.81% |
| 2023-01-13 | 3 | $9 | $5 | $6.333 | $0.288 | 2098.96% |
| 2023-04-03 | 3 | $9 | $3 | $5.666 | $0.288 | 1867.36% |
| 2023-04-04 | 2 | $4 | $4 | $4 | $0.288 | 1288.89% |
| 2023-04-06 | 3 | $5 | $3 | $4 | $0.288 | 1288.89% |
| 2023-06-02 | 2 | $4 | $2 | $3 | $0.288 | 941.67% |
| 2023-10-13 | 2 | $4 | $1 | $2.5 | $0.288 | 768.06% |
The Trend in the Analyst Price Target
PCSA's average price target has moved down $14.5 over the prior 30 months.
Over the past 39 weeks, PCSA's average upside potential has been 696.44%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-13 | 3 | 9 | 5 | 6.333 | 1.25 | 406.64% |
| 2023-04-04 | 2 | 5 | 3 | 4.000 | 0.49 | 716.33% |
| 2023-04-04 | 3 | 4 | 4 | 4.000 | 0.49 | 716.33% |
| 2023-04-04 | 2 | 4 | 4 | 4.000 | 0.49 | 716.33% |
| 2023-04-06 | 2 | 5 | 3 | 4.000 | 0.47 | 751.06% |
PCSA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
PCSA's average broker recommendation rating improved by 1 over the prior 34 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PCSA has a higher upside potential (average analyst target price relative to current price) than 1877.47% of all US stocks.
- In terms of how PROCESSA PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 79.65% of that group.
- PROCESSA PHARMACEUTICALS INC's average analyst price target is greater than 298.35% of Healthcare stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PROCESSA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -448.54% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PROCESSA PHARMACEUTICALS INC are MNPR, CNSP, and TRVI.
View All Top Stocks by Price Target
Make investment decisions regarding PCSA using the data that counts. Try POWR Ratings for free.